Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways.
Shengwen ChengSenrui LiuBowen ChenChengcheng DuPengcheng XiaoXuefeng LuoLi WeiYiting LeiChen ZhaoWei HuangPublished in: Chinese medicine (2023)
PSO may suppress osteosarcoma via the FAK and PI3K/Akt signaling pathways by downregulating ITGB1 expression.